Related Experiment Video
Updated: Aug 23, 2026

Determination of High-affinity Antibody-antigen Binding Kinetics Using Four Biosensor Platforms
Published on: April 17, 2017
Determination of the binding parameter constants of Renagel capsules and tablets at pH 7 by high performance
Ronald A Swearingen1, Eugene Zhorov, Aharon Cohen
1Genzyme Drug Discovery and Development, 153 Second Avenue, Waltham, MA 02451, USA. ronald.swearingen@genyme.com
Abstract:
Sevelamer hydrochloride is a cross-linked polymeric amine; it is the active ingredient in Renagel capsules and tablets. Sevelamer hydrochloride is indicated for the control of hyperphosphatemia in patients with end-stage renal disease (ESRD). The binding parameter constants of sevelamer hydrochloride were determined using high performance capillary electrophoresis (HPCE) and the Langmuir approximation for three different dosage forms at pH 7.0. The three dosage forms were Renagel 403 mg capsules, Renagel 400 mg tablets and Renagel 800 mg tablets. The results demonstrate the in vitro bioequivalence of all three dosage forms at pH 7.0. These results are in very good agreement with previously published results obtained by ion chromatography.
Related Concept Videos
Protein-Drug Binding: Determination Methods
Indirect methods involve isolating the bound drug from its free form in biological samples such as blood, serum, or plasma. These techniques aim to measure the percentage of drugs bound to proteins. Equilibrium dialysis is a commonly used method where the free drug concentration at equilibrium is measured by separating the bound...
Capillary Electrophoresis: Instrumentation
Electrophoresis: Overview
There...
Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations
Renal Drug Excretion: Effect of Urine pH, Flow Rate, and Drug pKa
The pKa of a drug,...
Analyte Adsorption and Distribution
